Medivis, Inc. v. Novarad Corp.

Court of Appeals for the Federal Circuit·Decided December 10, 2025·No. 24-1951·Unpublished

Opinion

Case: 24-1951 Document: 41 Page: 1 Filed: 12/10/2025

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

MEDIVIS, INC., Appellant

v.

NOVARAD CORP., Appellee ______________________

2024-1951 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2023- 00045. ______________________

JUDGMENT ______________________

ADAM STEINMETZ, Desmarais LLP, Washington, DC, argued for appellant. Also represented by BETTY H. CHEN, San Francisco, CA; TAEG SANG CHO, JOHN M. DESMARAIS, New York, NY.

JOSEPH HARMER, Thorpe North & Western, LLP, Salt Lake City, UT, argued for appellee. Also represented by JED H. HANSEN. ______________________ Case: 24-1951 Document: 41 Page: 2 Filed: 12/10/2025

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (PROST, CLEVENGER, and TARANTO, Cir- cuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 10, 2025 Date

Free access — add to your briefcase to read the full text and ask questions with AI

Medivis, Inc. v. Novarad Corp., (Fed. Cir. 2025).

Medivis, Inc. v. Novarad Corp. (Medivis, Inc. v. Novarad Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.